Ovarian Cancer
ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study ofTumor Treating Fields (TTFields, 200kHz) Concomitant with WeeklyPaclitaxel for the Treatment of Recurrent Ovarian Cancer
- Details
ClinicalTrials.gov ID:
NCT03940196
Diagnosis Type:
NA
USOR Number:
- Address
2312 N Nevada Ave, Suite 400
Colorado
Springs, CO 80907
P: (719) 577-2555